Argatroban: A synthetic thrombin inhibitor of low relative molecular mass

被引：39

作者：

Fitzgerald, D ^{[1
]}

Murphy, N ^{[1
]}

机构：

[1] ROYAL COLL SURGEONS IRELAND, CTR CARDIOVASC SCI, DUBLIN, IRELAND

来源：

CORONARY ARTERY DISEASE | 1996年 / 7卷 / 06期

基金：

英国惠康基金;

关键词：

thrombin; thrombin inhibitor; argatroban; thrombosis;

D O I：

10.1097/00019501-199606000-00008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Argatroban is an arginine derivative that is a highly specific thrombin inhibitor. Experimentally, it is more effective than heparin but it is not known whether this is the case in humans. The trials reported with argatroban to date have been too small to define either the efficacy or the safety of the drug. Large-scale clinical trials are under way in a variety of settings, including unstable angina, coronary angioplasty and acute myocardial infarction.

引用

页码：455 / 458

页数：4

共 32 条

[1]

BANNER DW, 1991, J BIOL CHEM, V266, P20085

[2]

BERRY CN, 1994, THROMB HAEMOSTASIS, V72, P381

[3] ANTITHROMBOTIC ACTIONS OF ARGATROBAN IN RAT MODELS OF VENOUS, MIXED AND ARTERIAL THROMBOSIS, AND ITS EFFECTS ON THE TAIL TRANSECTION BLEEDING-TIME [J].

BERRY, CN ;

GIRARD, D ;

LOCHOT, S ;

LECOFFRE, C .

BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1209-1214

[4] GEOMETRY OF BINDING OF THE BENZAMIDINE-BASED AND ARGININE-BASED INHIBITORS N-ALPHA-(2-NAPHTHYL-SULFONYL-GLYCYL)-DL-PARA-AMIDINOPHENYLALANYL-PIPERIDINE (NAPAP) AND (2R,4R)-4-METHYL-1-[N-ALPHA-(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINESULPHONYL)-L-ARGINYL]-2-PIPERIDINE CARBOXYLIC-ACID (MQPA) TO HUMAN ALPHA-THROMBIN - X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE NAPAP-TRYPSIN COMPLEX AND MODELING OF NAPAP-THROMBIN AND MQPA-THROMBIN [J].

BODE, W ;

TURK, D ;

STURZEBECHER, J .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 193 (01) :175-182

[5] COMPARATIVE-STUDIES ON THE ANTICOAGULANT AND PROTEASE GENERATION INHIBITORY ACTIONS OF NEWLY DEVELOPED SITE-DIRECTED THROMBIN INHIBITORY DRUGS - EFEGATRAN(R), ARGATROBAN, HIRULOG, AND HIRUDIN [J].

CALLAS, DD ;

HOPPENSTEADT, D ;

FAREED, J .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1995, 21 (02) :177-183

[6] COMBINED ADMINISTRATION OF ASPIRIN AND A SPECIFIC THROMBIN INHIBITOR IN MAN [J].

CLARKE, RJ ;

MAYO, G ;

FITZGERALD, GA ;

FITZGERALD, DJ .

CIRCULATION, 1991, 83 (05) :1510-1518

[7] THROMBIN IS AN IMPORTANT MEDIATOR OF PLATELET-AGGREGATION IN STENOSED CANINE CORONARY-ARTERIES WITH ENDOTHELIAL INJURY [J].

EIDT, JF ;

ALLISON, P ;

NOBLE, S ;

ASHTON, J ;

GOLINO, P ;

MCNATT, J ;

BUJA, LM ;

WILLERSON, JT .

JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (01) :18-27

[8] ROLE OF THROMBIN AND THROMBOXANE-A2 IN REOCCLUSION FOLLOWING CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].

FITZGERALD, DJ ;

FITZGERALD, GA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) :7585-7589

[9] EVIDENCE FOR A REBOUND COAGULATION PHENOMENON AFTER CESSATION OF A 4-HOUR INFUSION OF A SPECIFIC THROMBIN INHIBITOR IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS [J].

GOLD, HK ;

TORRES, FW ;

GARABEDIAN, HD ;

WERNER, W ;

JANG, IK ;

KHAN, A ;

HAGSTROM, JN ;

YASUDA, T ;

LEINBACH, RC ;

NEWELL, JB ;

BOVILL, EG ;

STUMP, DC ;

COLLEN, D .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (05) :1039-1047

[10]

HAITAS B, 1992, CLIN RES, V40, pA202

← 1 2 3 4 →